Zusamenfassung
Somit werden unter der Bezeichnung LN die atypische lobuläre Hyperplasie (ALH) und das lobuläre Carcinoma in situ (LCIS) zusammengefasst. Als Besonderheit der LN ist dessen häufig multizentrisches (46–85%) und bilaterales Auftreten (30–67%) zu beachten.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aberle DR, Allegra CJ, Ganschow P, et al. (2009) NIH State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ (DCIS). NIH Consens State Sci Statements 26: 2
Albert US, Altland H, Duda V, et al. (2008) Stufe-3-Leitlinie Brustkrebsfrüherkennung in Deutschland. Zuckschwerdt, München
Allred DC, Bryant J, Land S, et al. (2002) Estrogen receptor expression as a predictive marker of the effectiveness of tamoxifen in the treatment of DCIS: Findings from NSABP protocol B-24. Breast Cancer Res Treat 76(1 Suppl.1): S36
Bijker N, Peterse JL, Duchateau L, et al. (2001) Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research andTreatment of Cancer Trial 10853.J Clin Oncol 19: 2263–2271
Bratthauer GL, Tavassoli FA (2002) Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 440: 134–138
Cuzick J, Sestak I, Pinder SE, et al. (2009) Benefical Effect of Tamoxifen for Women with DCIS: Long-Term Results from the UK / ANZ DCIS Trial in Women with Locally Excised DCIS. San Antonio Breast Cancer Symposium, December 11, 2009, abstr 34
Dunne C, Burke JP, Morrow M, et al. (2009) Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 27: 1615–1620
Faverly DR, Burgers L, Bult P, et al. (1994) Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 11: 193–198
Fisher B, Dignam J, Wolmark N, et al. (1999) Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 353: 1993–2000
Fisher B, Land S, Mamounas E, et al. (2001) Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 28: 400–418
Goodwin A, Parker S, Ghersi D, et al. (2009) Post-operative radiotherapy for ductal carcinoma in situ of the breast—a systematic review of the randomised trials. Breast 18: 143–149
Harris JR, Morrow M (2009) Clinical dilemma of ductal carcinoma in situ. J Clin Oncol 27: 5303–5305
Hughes LL, Wang M, Page DL, et al. (2009) Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27: 5319–5324
Kreienberg R, Kopp I, Albert US, et al. (2008) Interdisziplinäre S3-Leitliniefür die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. Zuckschwerdt, München
Lebeau A (2006) Prognostic factors in ductal carcinoma in situ. Pathologe 27: 326–336
Leonard GD, Swain SM (2004) Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 96: 906–920
Maass N, Alkasi O, Bauer M, et al. (2009) Actual management of ductal carcinoma in situ of the breast. Arch Gynecol Obstet 280: 699–705
McLaren BK, Schuyler PA, Sanders ME, et al. (2006) Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy. Cancer 107: 1227–1233
Menon S, Porter GJ, Evans AJ, et al. (2008) The significance of lobular neoplasia on needle core biopsy of the breast. Virchows Arch 452: 473–479
Nährig J (2008) Practical problems in breast screening. Columnar cell lesions including flat epithelial atypia and lobular neoplasia. Pathologe 29Suppl 2: 172–177
Page DL, Schuyler PA, Dupont WD, et al. (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361: 125–129
Silverstein MJ (2003) The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 186: 337–343
Silverstein MJ, Buchanan C (2003) Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margin status. Breast 12: 457–471
Silverstein MJ, Poller DN, Waisman JR, et al. (1995) Prognostic classification of breast ductal carcinoma-in-situ. Lancet 345: 1154–1157
Sinn HP, Helmchen B, Aulmann S (2006) Concepts and problems of lobular neoplasia. Pathologe 27: 373–380
Tavassoli FA, Eusebi V (2009) Tumors of the mammary gland. The American Registry of Pathology: Washington, DC
Thomas J, Evans A, Macartney J, et al. (2010) Radiological and pathological size estimations of pure ductal carcinoma in situ of the breast, specimen handling and the influence on the success of breast conservation surgery: a review of 2564 cases from the Sloane Project. Br J Cancer 102: 285–293
Wickerham DL, Costantino JP, Vogel VG, et al. (2009) The use of tamoxifen and raloxifene for the prevention of breast cancer. Recent Results Cancer Res 181: 113–119
Wong JS, Kaelin CM, Troyan SL, et al. (2006) Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 24: 1031–1036
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg New York
About this chapter
Cite this chapter
Lebeau, A. (2010). Management der In-situ-Karzinome. In: Mammakarzinom Interdisziplinär. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12681-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-12681-9_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12680-2
Online ISBN: 978-3-642-12681-9
eBook Packages: Medicine (German Language)